Veliparib is a benzimidazole derivative with a carbamoyl group and a pyrrolidinyl substituent. It is a potent, orally bioavailable inhibitor of poly(ADP-ribose) polymerase (PARP), acting as an EC 2.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Veliparib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Rucaparib
pharmaceutical raw material
Difloxacin hydrochloride
pharmaceutical raw material
Sarafloxacin hydrochloride
pharmaceutical raw material
Cenobamate
pharmaceutical raw material
(1S)-1-(2-chlorophenyl)-2-(2H-1,2,3,4-tetrazol-2-yl)ethyl carbamate
pharmaceutical raw material
The international HS code for Veliparib (CAS 912444-00-9) is 2933.99.
2933.99
2933 99 80
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide
JNAHVYVRKWKWKQ-CYBMUJFWSA-N
C[C@@]1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N
Sourcing Veliparib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.